CN104721530A - Antihypertensive traditional Chinese medicine composition - Google Patents
Antihypertensive traditional Chinese medicine composition Download PDFInfo
- Publication number
- CN104721530A CN104721530A CN201510089636.2A CN201510089636A CN104721530A CN 104721530 A CN104721530 A CN 104721530A CN 201510089636 A CN201510089636 A CN 201510089636A CN 104721530 A CN104721530 A CN 104721530A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- portions
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating high blood pressure. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 10-30 parts of angelica, 10-30 parts of astragalus membranaceus, 10-30 parts of poria cocos, 5-15 parts of rhizoma atractylodis, 5-15 parts of root of rehmannia, 5-15 parts of radix bupleuri, 5-15 parts of salvia miltiorrhiza, 6-10 parts of semen cassia, 6-10 parts of radix ophiopogonis, 6-10 parts of ligusticum wallichii, 5-15 parts of rehmannia glutinosa, 5-15 parts of lotus leaf, 5-15 parts of peach kernel, 10-30 parts of mother chrysanthemum, 6-10 parts of moutan bark, 6-10 parts of fructus aurantii, 10-30 parts of honeysuckle, 10-30 parts of gynura bicolor, 10-30 parts of radix puerariae, 5-15 parts of codonopsis pilosula, 5-15 parts of folium apocyni veneti and 5-15 parts of felwort.
Description
Technical field
The present invention relates to technical field of Chinese medicines, be specifically related to a kind of blood pressure lowering Chinese medicinal composition.
Background technology
The blood pressure of normal person fluctuates within the specific limits with internal and external environment change.Overall crowd, blood pressure level raised gradually with the age, more obvious with systolic pressure, but after 50 years old, diastolic pressure presents downward trend, and pulse pressure also strengthens thereupon.In recent years; the understanding of people to the effect of cardiovascular diseases's multiple risk factors and the heart, brain, kidney target-organ protection deepens continuously; hypertensive diagnostic criteria is also in continuous adjustment; think that the danger difference of cardiovascular diseases occurs the patient of same blood pressure level at present; therefore the concept of blood pressure layering has been had; namely the different patient of cardiovascular diseases's risk factor occurs, and suitable blood pressure level should have difference.Hypertension is the disease of lasting hyperpiesia, the diseases such as apoplexy, heart disease, hemangioma, renal failure can be caused, hypertension be a kind of with arterial pressure rising for feature, can with the systemic disease of the functional or organic change of heart, blood vessel, brain and kidney and other organs, the hypertensive method of current treatment mainly medicine blood pressure lowering is aided with dietetic therapy, but the most of Western medicine of medicine used, need long-term taking, side effect is comparatively large and medicine is expensive, brings very heavy financial burden to patient.
Summary of the invention
Be to provide one according to the technical problem that will solve of the invention described above and treat hypertensive Chinese medicine composition, its raw material is pure natural Chinese herbal medicine, cheap, has no side effect.
The technical scheme that the present invention takes is:
One treats hypertensive Chinese medicine composition, be made up of following raw material: 10 ?30 parts of Radix Angelicae Sinensis, 10 ?30 parts of Radixs Astragali, 10 ?30 parts of Poria, 5 ?15 parts of Rhizoma Atractylodis, 5 ?15 parts of Radix Rehmanniae, 5 ?15 parts of Radix Bupleuri, 5 ?15 parts of Radix Salviae Miltiorrhizaes, 6 ?10 parts of Semen Cassiaes, 6 ?10 parts of Radix Ophiopogonis, 6 ?10 parts of Rhizoma Chuanxiongs, 5 ?15 parts of Radix Rehmanniaes Preparata, 5 ?15 parts of Folium Nelumbinis, 5 ?15 parts of Semen Persicaes, 10 ?30 parts of Flos Chrysanthemi Indicis, 6 ?10 parts of Cortex Moutans, 6 ?10 parts of Fructus Aurantiis, 10 ?30 portions of Flos Loniceraes, 10 ?30 parts of Radix Semiaquilegiae, 10 ?30 parts of Radix Puerariaes, 5 ?15 parts of Radix Codonopsis, 5 ?15 parts of Folium Apocyni Venetves, 5 ?15 portions of Radix Gentianaes.
Preferably, one treats hypertensive Chinese medicine composition, be made up of following raw material: 15 ?25 parts of Radix Angelicae Sinensis, 15 ?25 parts of Radixs Astragali, 15 ?25 parts of Poria, 8 ?12 parts of Rhizoma Atractylodis, 8 ?12 parts of Radix Rehmanniae, 8 ?12 parts of Radix Bupleuri, 8 ?12 parts of Radix Salviae Miltiorrhizaes, 7 ?9 parts of Semen Cassiaes, 7 ?9 parts of Radix Ophiopogonis, 7 ?9 parts of Rhizoma Chuanxiongs, 8 ?12 parts of Radix Rehmanniaes Preparata, 8 ?12 parts of Folium Nelumbinis, 8 ?12 parts of Semen Persicaes, 15 ?25 parts of Flos Chrysanthemi Indicis, 7 ?9 parts of Cortex Moutans, 7 ?9 parts of Fructus Aurantiis, 15 ?25 portions of Flos Loniceraes, 15 ?25 parts of Radix Semiaquilegiae, 15 ?25 parts of Radix Puerariaes, 8 ?12 parts of Radix Codonopsis, 8 ?12 parts of Folium Apocyni Venetves, 8 ?12 portions of Radix Gentianaes.
More preferably, one treats hypertensive Chinese medicine composition, is made up of following raw material: 20 parts of Radix Angelicae Sinensis, 20 parts of Radixs Astragali, 20 parts of Poria, 10 parts of Rhizoma Atractylodis, 10 parts of Radix Rehmanniae, 10 parts of Radix Bupleuri, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Semen Cassiaes, 8 parts of Radix Ophiopogonis, 8 parts of Rhizoma Chuanxiongs, 10 parts of Radix Rehmanniaes Preparata, 10 parts of Folium Nelumbinis, 10 parts of Semen Persicaes, 20 parts of Flos Chrysanthemi Indicis, 8 parts of Cortex Moutans, 8 parts of Fructus Aurantiis, 20 portions of Flos Loniceraes, 20 parts of Radix Semiaquilegiae, 20 parts of Radix Puerariaes, 10 parts of Radix Codonopsis, 10 portions of Folium Apocyni Venetves, 10 portions of Radix Gentianaes.
Said medicine is according to the preparation of common Chinese compound method and take.
Blood pressure lowering Chinese medicinal composition of the present invention, each taste medicine, property is flat gentle, scientific formulation, Be very effective, and cost is low, and manufacture method is simple, is easy to large-scale production.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
One treats hypertensive Chinese medicine composition, is made up of following raw material: 10 parts of Radix Angelicae Sinensis, 10 parts of Radixs Astragali, 10 parts of Poria, 5 parts of Rhizoma Atractylodis, 5 parts of Radix Rehmanniae, 5 parts of Radix Bupleuri, 5 parts of Radix Salviae Miltiorrhizaes, 6 parts of Semen Cassiaes, 6 parts of Radix Ophiopogonis, 6 parts of Rhizoma Chuanxiongs, 5 parts of Radix Rehmanniaes Preparata, 5 parts of Folium Nelumbinis, 5 parts of Semen Persicaes, 10 parts of Flos Chrysanthemi Indicis, 6 parts of Cortex Moutans, 6 parts of Fructus Aurantiis, 10 portions of Flos Loniceraes, 10 parts of Radix Semiaquilegiae, 10 parts of Radix Puerariaes, 5 parts of Radix Codonopsis, 5 portions of Folium Apocyni Venetves, 5 portions of Radix Gentianaes.
Embodiment 2
One treats hypertensive Chinese medicine composition, is made up of following raw material: 15 parts of Radix Angelicae Sinensis, 15 parts of Radixs Astragali, 15 parts of Poria, 8 parts of Rhizoma Atractylodis, 8 parts of Radix Rehmanniae, 8 parts of Radix Bupleuri, 8 parts of Radix Salviae Miltiorrhizaes, 7 parts of Semen Cassiaes, 7 parts of Radix Ophiopogonis, 7 parts of Rhizoma Chuanxiongs, 8 parts of Radix Rehmanniaes Preparata, 8 parts of Folium Nelumbinis, 8 parts of Semen Persicaes, 15 parts of Flos Chrysanthemi Indicis, 7 parts of Cortex Moutans, 7 parts of Fructus Aurantiis, 15 portions of Flos Loniceraes, 15 parts of Radix Semiaquilegiae, 15 parts of Radix Puerariaes, 8 parts of Radix Codonopsis, 8 portions of Folium Apocyni Venetves, 8 portions of Radix Gentianaes.
Embodiment 3
One treats hypertensive Chinese medicine composition, is made up of following raw material: 20 parts of Radix Angelicae Sinensis, 20 parts of Radixs Astragali, 20 parts of Poria, 10 parts of Rhizoma Atractylodis, 10 parts of Radix Rehmanniae, 10 parts of Radix Bupleuri, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Semen Cassiaes, 8 parts of Radix Ophiopogonis, 8 parts of Rhizoma Chuanxiongs, 10 parts of Radix Rehmanniaes Preparata, 10 parts of Folium Nelumbinis, 10 parts of Semen Persicaes, 20 parts of Flos Chrysanthemi Indicis, 8 parts of Cortex Moutans, 8 parts of Fructus Aurantiis, 20 portions of Flos Loniceraes, 20 parts of Radix Semiaquilegiae, 20 parts of Radix Puerariaes, 10 parts of Radix Codonopsis, 10 portions of Folium Apocyni Venetves, 10 portions of Radix Gentianaes.
Embodiment 4
One treats hypertensive Chinese medicine composition, is made up of following raw material: 25 parts of Radix Angelicae Sinensis, 25 parts of Radixs Astragali, 25 parts of Poria, 12 parts of Rhizoma Atractylodis, 12 parts of Radix Rehmanniae, 12 parts of Radix Bupleuri, 12 parts of Radix Salviae Miltiorrhizaes, 9 parts of Semen Cassiaes, 9 parts of Radix Ophiopogonis, 9 parts of Rhizoma Chuanxiongs, 12 parts of Radix Rehmanniaes Preparata, 12 parts of Folium Nelumbinis, 12 parts of Semen Persicaes, 25 parts of Flos Chrysanthemi Indicis, 9 parts of Cortex Moutans, 9 parts of Fructus Aurantiis, 25 portions of Flos Loniceraes, 25 parts of Radix Semiaquilegiae, 25 parts of Radix Puerariaes, 12 parts of Radix Codonopsis, 12 portions of Folium Apocyni Venetves, 12 portions of Radix Gentianaes.
Embodiment 5
One treats hypertensive Chinese medicine composition, is made up of following raw material: 30 parts of Radix Angelicae Sinensis, 30 parts of Radixs Astragali, 30 parts of Poria, 15 parts of Rhizoma Atractylodis, 15 parts of Radix Rehmanniae, 15 parts of Radix Bupleuri, 15 parts of Radix Salviae Miltiorrhizaes, 10 parts of Semen Cassiaes, 10 parts of Radix Ophiopogonis, 10 parts of Rhizoma Chuanxiongs, 15 parts of Radix Rehmanniaes Preparata, 15 parts of Folium Nelumbinis, 15 parts of Semen Persicaes, 30 parts of Flos Chrysanthemi Indicis, 10 parts of Cortex Moutans, 10 parts of Fructus Aurantiis, 30 portions of Flos Loniceraes, 30 parts of Radix Semiaquilegiae, 30 parts of Radix Puerariaes, 15 parts of Radix Codonopsis, 15 portions of Folium Apocyni Venetves, 15 portions of Radix Gentianaes.
Should be understood that this embodiment is only not used in for illustration of the present invention to limit the scope of the invention.In addition, should be understood that those skilled in the art can make various changes or modifications the present invention, and these equivalent form of values fall within the protection domain that the application's appended claims limits equally after having read the content that the present invention lectures.
Claims (3)
1. the hypertensive Chinese medicine composition for the treatment of, it is characterized in that being made up of following raw material: 10 ?30 parts of Radix Angelicae Sinensis, 10 ?30 parts of Radixs Astragali, 10 ?30 parts of Poria, 5 ?15 parts of Rhizoma Atractylodis, 5 ?15 parts of Radix Rehmanniae, 5 ?15 parts of Radix Bupleuri, 5 ?15 parts of Radix Salviae Miltiorrhizaes, 6 ?10 parts of Semen Cassiaes, 6 ?10 parts of Radix Ophiopogonis, 6 ?10 parts of Rhizoma Chuanxiongs, 5 ?15 parts of Radix Rehmanniaes Preparata, 5 ?15 parts of Folium Nelumbinis, 5 ?15 parts of Semen Persicaes, 10 ?30 parts of Flos Chrysanthemi Indicis, 6 ?10 parts of Cortex Moutans, 6 ?10 parts of Fructus Aurantiis, 10 ?30 portions of Flos Loniceraes, 10 ?30 parts of Radix Semiaquilegiae, 10 ?30 parts of Radix Puerariaes, 5 ?15 parts of Radix Codonopsis, 5 ?15 parts of Folium Apocyni Venetves, 5 ?15 portions of Radix Gentianaes.
2. the hypertensive Chinese medicine composition for the treatment of according to claim 1, it is characterized in that being made up of following raw material: 15 ?25 parts of Radix Angelicae Sinensis, 15 ?25 parts of Radixs Astragali, 15 ?25 parts of Poria, 8 ?12 parts of Rhizoma Atractylodis, 8 ?12 parts of Radix Rehmanniae, 8 ?12 parts of Radix Bupleuri, 8 ?12 parts of Radix Salviae Miltiorrhizaes, 7 ?9 parts of Semen Cassiaes, 7 ?9 parts of Radix Ophiopogonis, 7 ?9 parts of Rhizoma Chuanxiongs, 8 ?12 parts of Radix Rehmanniaes Preparata, 8 ?12 parts of Folium Nelumbinis, 8 ?12 parts of Semen Persicaes, 15 ?25 parts of Flos Chrysanthemi Indicis, 7 ?9 parts of Cortex Moutans, 7 ?9 parts of Fructus Aurantiis, 15 ?25 portions of Flos Loniceraes, 15 ?25 parts of Radix Semiaquilegiae, 15 ?25 parts of Radix Puerariaes, 8 ?12 parts of Radix Codonopsis, 8 ?12 parts of Folium Apocyni Venetves, 8 ?12 portions of Radix Gentianaes.
3. the hypertensive Chinese medicine composition for the treatment of according to claim 1 and 2, is characterized in that being made up of following raw material: 20 parts of Radix Angelicae Sinensis, 20 parts of Radixs Astragali, 20 parts of Poria, 10 parts of Rhizoma Atractylodis, 10 parts of Radix Rehmanniae, 10 parts of Radix Bupleuri, 10 parts of Radix Salviae Miltiorrhizaes, 8 parts of Semen Cassiaes, 8 parts of Radix Ophiopogonis, 8 parts of Rhizoma Chuanxiongs, 10 parts of Radix Rehmanniaes Preparata, 10 parts of Folium Nelumbinis, 10 parts of Semen Persicaes, 20 parts of Flos Chrysanthemi Indicis, 8 parts of Cortex Moutans, 8 parts of Fructus Aurantiis, 20 portions of Flos Loniceraes, 20 parts of Radix Semiaquilegiae, 20 parts of Radix Puerariaes, 10 parts of Radix Codonopsis, 10 portions of Folium Apocyni Venetves, 10 portions of Radix Gentianaes.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510089636.2A CN104721530A (en) | 2015-02-27 | 2015-02-27 | Antihypertensive traditional Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510089636.2A CN104721530A (en) | 2015-02-27 | 2015-02-27 | Antihypertensive traditional Chinese medicine composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104721530A true CN104721530A (en) | 2015-06-24 |
Family
ID=53446326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510089636.2A Pending CN104721530A (en) | 2015-02-27 | 2015-02-27 | Antihypertensive traditional Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104721530A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421101A (en) * | 2016-11-30 | 2017-02-22 | 河南中医药大学 | Traditional Chinese medicine composition for treating diabetes combined with cerebral ischemia |
| CN107261015A (en) * | 2017-06-21 | 2017-10-20 | 佛山科学技术学院 | A kind of anti-hypertensive electuary and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670070A (en) * | 2009-09-09 | 2010-03-17 | 卢庆武 | Traditional Chinese medicine composition for treating hypertension |
| CN102940787A (en) * | 2012-11-09 | 2013-02-27 | 西安福安创意咨询有限责任公司 | Traditional Chinese medicine for treating hypertension |
| CN103623248A (en) * | 2013-11-29 | 2014-03-12 | 高鑫 | Traditional Chinese medicinal composition for reducing blood pressure |
| CN103705596A (en) * | 2014-01-10 | 2014-04-09 | 肖小玉 | Traditional Chinese medicine for reducing blood pressure and preparation method thereof |
-
2015
- 2015-02-27 CN CN201510089636.2A patent/CN104721530A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670070A (en) * | 2009-09-09 | 2010-03-17 | 卢庆武 | Traditional Chinese medicine composition for treating hypertension |
| CN102940787A (en) * | 2012-11-09 | 2013-02-27 | 西安福安创意咨询有限责任公司 | Traditional Chinese medicine for treating hypertension |
| CN103623248A (en) * | 2013-11-29 | 2014-03-12 | 高鑫 | Traditional Chinese medicinal composition for reducing blood pressure |
| CN103705596A (en) * | 2014-01-10 | 2014-04-09 | 肖小玉 | Traditional Chinese medicine for reducing blood pressure and preparation method thereof |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106421101A (en) * | 2016-11-30 | 2017-02-22 | 河南中医药大学 | Traditional Chinese medicine composition for treating diabetes combined with cerebral ischemia |
| CN107261015A (en) * | 2017-06-21 | 2017-10-20 | 佛山科学技术学院 | A kind of anti-hypertensive electuary and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
| CN101134086A (en) | Traditional Chinese medicine for treating cervical vertigo | |
| CN101152536A (en) | Traditional Chinese medicine for treating hashimoto thyroiditis | |
| CN103623292A (en) | Traditional Chinese medicine composition for treating diabetes mellitus | |
| CN101130054A (en) | Traditional Chinese medicine for treating phlegm-turbidity internal-resistance type dizziness | |
| CN104721530A (en) | Antihypertensive traditional Chinese medicine composition | |
| CN103330821A (en) | Traditional Chinese medicine for treating chest stuffiness and heart pain | |
| CN1228063C (en) | Medicine for treating liver disease | |
| CN103463427B (en) | Medicinal tea for treating arteriosclerosis | |
| CN103446535B (en) | A kind of Miao Ethnomedicine for the treatment of coronary heart disease | |
| CN104721791A (en) | Pharmaceutical formulation for treating cardiovascular and cerebrovascular diseases | |
| CN103721020A (en) | Blood circulation promoting and meridian unlocking granule for treating cerebral thrombosis and preparation method of granule | |
| CN103393988A (en) | Infant anti-diarrheal decoction | |
| CN1814168A (en) | Medicine for treating hypertension and preparing method thereof | |
| CN104435780A (en) | Hypertension treating medicine | |
| CN105125894B (en) | A kind of Chinese medicine composition for treating headache | |
| CN103768520A (en) | Lipomata nursing medicine and preparation method thereof | |
| CN103349762B (en) | Traditional Chinese medicine used for treating type II diabetes | |
| CN103566279A (en) | Medicine for treating hypertension | |
| CN1966061A (en) | Medicinal decoction for treating qi stagnation type gestational edema and preparation process thereof | |
| CN102274409A (en) | Blood pressure lowering Chinese medicinal composition | |
| CN101129658A (en) | Traditional Chinese medicine for treating coronary heart disease and high blood viscosity | |
| CN101152498A (en) | Traditional Chinese medicine for treating dacryocystitis caused by acute dacryocystitis | |
| CN1634471A (en) | Chinese traditional medicine for treating cardiopathy | |
| CN106692721A (en) | Traditional Chinese medicine formula for treating nephritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150624 |
|
| WD01 | Invention patent application deemed withdrawn after publication |